‘Tekorten antibiotica gevolg van monopolie op grondstoffen’, reports NOS

Rinke van den Brink reports on the Foundation's new white paper about antibiotic shortages: "The increasingly frequent shortages of commonly used antibiotics are the result of monopolies or near-monopolies of the raw material producers ... According to Access to Medicine, pharmaceutical companies have little interest in to make the production and distribution chain for antibiotics more reliable. These are medicines that make relatively little money. They are cheap compared to many other means. Moreover, the demand is increasing in poor countries.